Contemporary role of endolymphatic mastoid shunt surgery in the era of transtympanic perfusion strategies

Annals of Otology, Rhinology and Laryngology

Volumn 117, Issue 12, 2008, Pages 871-875

  Lee, Lisa ^a   Pensak, Myles L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Endolymphatic hydrops; Endolymphatic mastoid shunt; Meniere's disease

Indexed keywords

GENTAMICIN; PREDNISONE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONDUCTION DEAFNESS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ENDOLYMPHATIC SAC; ENDOLYMPHATIC SHUNT; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEARING LOSS; HUMAN; LIQUORRHEA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MASTOIDECTOMY; MENIERE DISEASE; PERCEPTION DEAFNESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VERTIGO; CLASSIFICATION; EARDRUM; HOSPITALIZATION; INNER EAR; MIDDLE AGED; RETROSPECTIVE STUDY; VESTIBULAR NERVE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; EAR, INNER; ENDOLYMPHATIC SHUNT; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TYMPANIC MEMBRANE; VERTIGO; VESTIBULAR NERVE; YOUNG ADULT;

EID: 59649089183     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940811701201     Document Type: Article

References (30)

1. Pensak ML, Friedman RA. The role of endolymphatic mastoid shunt surgery in the managed care era. Am J Otol 1998;19:337-40.
2. Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's disease. Otol Neurotol 2003;24:800-6.
3. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-20.
4. Carey J. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo. Otolaryngol Clin North Am 2004;37:1075-90.
5. De Beer L, Stokroos R, Kingma H. Intratympanic gentamicin therapy for intractable Ménière's disease. Acta Otolaryngol 2007;127:605-12.
6. De Stefano A, Dispenza F, De Donato G, Caruso A, Taibah A, Sanna M. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease. Am J Otolaryngol 2007;28:289-93.
7. Barrs DM. Intratympanic injections of dexamethasone for long-term control of vertigo. Laryngoscope 2004;114:1910-4.
8. Barrs DM, Keyser JS, Stallworth C, McElveen JT Jr. Intratympanic steroid injections for intractable Ménière's disease. Laryngoscope 2001;111:2100-4.
9. Boleas-Aguirre MS, Lin FR, Della Santina CC, Minor LB, Carey JP. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease. Otol Neurotol 2008;29:33-8.
10. Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005;133:285-94.
11. Brinson GM, Chen DA, Arriaga MA. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Mé nière's disease. Otolaryngol Head Neck Surg 2007;136:415-21.
12. Huang TS. Endolymphatic sac surgery for Meniere's disease: experience with over 3000 cases. Otolaryngol Clin North Am 2002;35:591-606.
13. Paparella MM, Fina M. Endolymphatic sac enhancement: reversal of pathogenesis. Otolaryngol Clin North Am 2002;35:621-37.
14. Quaranta A, Marini F, Sallustio V. Long-term outcome of Ménière's disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol 1998;3:54-60.
15. Kim HH, Wiet RJ, Battista RA. Trends in the diagnosis and the management of Meniere's disease: results of a survey. Otolaryngol Head Neck Surg 2005;132:722-6.
16. Bretlau P, Thomsen J, Tos M, Johnsen NJ. Placebo effect in surgery for Menière's disease: nine-year follow-up. Am J Otol 1989;10:259-61.
17. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-5.
18. Arenberg IK, Rask-Andersen H, Wilbrand H, Stahle J. The surgical anatomy of the endolymphatic sac. Arch Otolaryngol 1977;103:1-11.
19. Harris JP. Inner ear steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2007;15:303.
20. Dodson KM, Woodson E, Sismanis A. Intratympanic steroid perfusion for the treatment of Ménière's disease: a retrospective study. Ear Nose Throat J 2004;83:394-8.
21. Doyle KJ, Bauch C, Battista R, et al. Intratympanic steroid treatment: a review. Otol Neurotol 2004;25:1034-9.
22. Atlas J, Parnes LS. Intratympanic gentamicin for intractable Ménière's disease: 5-year follow-up. J Otolaryngol 2003;32:288-93.
23. Flanagan S, Mukherjee P, Tonkin J. Outcomes in the use of intra-tympanic gentamicin in the treatment of Ménière's disease. J Laryngol Otol 2006;120:98-102.
24. Silverstein H, Lewis WB, Jackson LE, Rosenberg SI, Thompson JH, Hoffmann KK. Changing trends in the surgical treatment of Ménière's disease: results of a 10-year survey. Ear Nose Throat J 2003;82:185-7, 191-4.
25. Thomsen J, Bretlau P, Tos M, Johnsen NJ. Ménière's disease: a 3-year follow-up of patients in a double-blind placebo-controlled study on endolymphatic sac shunt surgery. Adv Otorhinolaryngol 1983;30:350-4.
26. Convert C, Franco-Vidal V, Bebear JP, Darrouzet V. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients. Otol Neurotol 2006;27:687-96.
27. Durland WF Jr, Pyle GM, Connor NP. Endolymphatic sac decompression as a treatment for Ménière's disease. Laryngoscope 2005;115:1454-7.
28. Goldenberg RA, Justus MA. Endolymphatic mastoid shunt for treatment of Ménière's disease: a five year study. Laryngoscope 1983;93:1425-9.
29. Telischi FF, Luxford WM. Long-term efficacy of endolymphatic sac surgery for vertigo in Menière's disease. Otolaryngol Head Neck Surg 1993;109:83-7.
30. Kato BM, LaRouere MJ, Bojrab DI, Michaelides EM. Evaluating quality of life after endolymphatic sac surgery: The Ménière's Disease Outcomes Questionnaire. Otol Neurotol 2004;25:339-44.